Elixxer Ltd.
ELIXF
Rank in Stocks
#31891
Elixxer Ltd. operates as an investment company specifically focused on the... Elixxer Ltd. operates as an investment company specifically focused on the cannabis industry. This firm strategically deploys capital into fully licensed businesses engaged in the cultivation, production, and sale of medicinal and specialized cannabis, as well as cannabis-derived products, predominantly for the pharmaceutical sector. Its investment reach extends across Canada, Australia, Italy, Jamaica, and Switzerland. Founded in 2004, the Montreal, Canada-based company adopted its current name, Elixxer Ltd., in August 2019, having previously been known as LGC Capital Ltd.
Share Price
$0.0335
Last synced: 2026-11-16
Market Cap
$2.26M
Change (1 day)
0.00%
Change (1 year)
-44.07%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade Elixxer Ltd. (ELIXF)
Category
Healthcare
EPS for Elixxer Ltd. (ELIXF)
EPS as of June 2026 TTM: $-0.18
According to Elixxer Ltd.'s latest financial reports, its current EPS (TTM) is $-0.18. At the end of 2025 the company had an EPS of $-0.25, a decrease compared to its 2024 EPS of 0.00.
EPS history for Elixxer Ltd. from 2006 to 2026
EPS at the end of each year
| Year | EPS | Change |
|---|---|---|
| 2026 (TTM) | $-0.18 | -29.92% |
| 2025 | $-0.25 | 82,466.67% |
| 2024 | 0.00 | 50.00% |
| 2023 | 0.00 | -99.99% |
| 2022 | $-1.54 | 363.50% |
| 2021 | $-0.33 | -75.12% |
| 2020 | $-1.34 | -39.01% |
| 2019 | $-2.19 | -43.65% |
| 2018 | $-3.89 | 127.39% |
| 2017 | $-1.71 | -41.13% |
| 2016 | $-2.90 | 2,310.96% |
| 2015 | $-0.12 | -91.76% |
| 2014 | $-1.46 | 52.21% |
| 2013 | $-0.96 | 39.92% |
| 2012 | $-0.69 | -212.21% |
| 2011 | $0.61 | 7.86% |
| 2010 | $0.57 | -209.48% |
| 2009 | $-0.52 | -80.80% |
| 2008 | $-2.70 | -66.12% |
| 2007 | $-7.96 | 58.44% |
| 2006 | $-5.03 | 0.00% |
EPS for similar companies or competitors
| Company | EPS | EPS Difference | Country |
|---|---|---|---|
| $6.03 | -3,541.72% |
DE
|
|
| $6.01 | -3,529.11% |
DE
|
|
| $1.53 | -974.94% |
JP
|
|
| $3.66 | -2,189.04% |
CH
|
|
| $0.45 | -356.85% |
IL
|
Questions about Elixxer Ltd.'s earnings per share (EPS)
What is Elixxer Ltd.'s earnings per share (EPS)?
Elixxer Ltd.'s earnings per share (EPS) over the last twelve months is $-0.18, as of Jun 2026.
What was Elixxer Ltd.'s earnings per share (EPS) in 2025?
In 2025, Elixxer Ltd.'s earnings per share (EPS) was $-0.25, compared with 0.00 in 2024.
How has Elixxer Ltd.'s earnings per share (EPS) changed since 2020?
From 2020 to 2025, Elixxer Ltd.'s earnings per share (EPS) was highest in 2024 (0.00) and lowest in 2022 ($-1.54).
How does Elixxer Ltd.'s earnings per share (EPS) compare with similar companies?
Elixxer Ltd.'s earnings per share (EPS) ($-0.18) is lower than that of all 5 similar companies listed above. The highest among them is MERCK Kommanditgesellschaft auf Aktien, with $6.03.